GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$90.18
+2.72% today
Updated 2026-04-30
Market cap
$11.91B
P/E ratio
22.40
P/S ratio
4.05x
EPS (TTM)
$3.92
Dividend yield
—
52W range
$52 – $101
Volume
1.1M
Globus Medical (GMED) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.34M | $288.19M | $331.48M | $385.99M | $434.46M | $474.37M | $544.75M | $563.99M | $635.98M | $712.97M | $785.37M | $789.04M | $958.10M | $1.02B | $1.57B | $2.52B | $2.94B |
| Revenue growth (YoY) | — | +13.3% | +15.0% | +16.4% | +12.6% | +9.2% | +14.8% | +3.5% | +12.8% | +12.1% | +10.2% | +0.5% | +21.4% | +6.8% | +53.3% | +60.6% | +16.7% |
| Cost of revenue | $41.61M | $53.83M | $68.80M | $75.20M | $100.34M | $110.77M | $132.33M | $134.71M | $150.45M | $159.41M | $179.97M | $217.46M | $239.22M | $263.73M | $548.17M | $1.04B | $957.80M |
| Gross profit | $212.74M | $234.37M | $262.68M | $310.80M | $334.12M | $363.60M | $412.42M | $429.29M | $485.52M | $553.56M | $605.39M | $571.58M | $718.88M | $759.12M | $1.02B | $1.48B | $1.98B |
| Gross margin | 83.6% | 81.3% | 79.2% | 80.5% | 76.9% | 76.6% | 75.7% | 76.1% | 76.3% | 77.6% | 77.1% | 72.4% | 75.0% | 74.2% | 65.1% | 58.9% | 67.4% |
| R&D | $20.52M | $21.31M | $23.46M | $27.93M | $26.87M | $31.17M | $36.31M | $44.53M | $43.68M | $55.50M | $60.07M | $84.52M | $97.35M | $73.02M | $124.01M | $163.75M | $185.00M |
| SG&A | — | $143.90M | $163.93M | $168.86M | $182.52M | $187.80M | $214.01M | $222.16M | $267.82M | $311.59M | $354.76M | $354.76M | $408.15M | $432.12M | $643.41M | $981.05M | $1.18B |
| Operating income | $81.91M | $87.69M | $97.36M | $114.79M | $101.67M | $138.36M | $172.22M | $154.14M | $161.84M | $169.32M | $171.99M | $111.43M | $171.95M | $227.95M | $133.14M | $165.99M | $479.80M |
| Operating margin | 32.2% | 30.4% | 29.4% | 29.7% | 23.4% | 29.2% | 31.6% | 27.3% | 25.4% | 23.7% | 21.9% | 14.1% | 17.9% | 22.3% | 8.5% | 6.6% | 16.3% |
| EBITDA | $97.30M | $105.67M | $115.78M | $132.68M | $120.93M | $159.59M | $195.59M | $192.99M | $205.39M | $218.51M | $229.49M | $178.35M | $264.73M | $304.50M | $346.58M | $473.73M | $729.90M |
| EBITDA margin | 38.3% | 36.7% | 34.9% | 34.4% | 27.8% | 33.6% | 35.9% | 34.2% | 32.3% | 30.6% | 29.2% | 22.6% | 27.6% | 29.8% | 22.1% | 18.8% | 24.8% |
| EBIT | $83.79M | $90.47M | $98.83M | $114.57M | $101.53M | $137.84M | $171.50M | $154.22M | $163.32M | $176.88M | $176.75M | $115.47M | $194.86M | $236.25M | $201.85M | $219.70M | $609.90M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $805000.00 | $1.30M | $3.06M | $6.61M | $13.28M | $17.41M | $13.95M | $9.30M | $14.23M | $20.13M | $4.19M | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $48.73M | $54.46M | $60.78M | $73.83M | $68.61M | $92.48M | $112.78M | $104.34M | $107.35M | $156.47M | $155.21M | $102.28M | $149.19M | $190.17M | $122.87M | $102.98M | $537.90M |
| Net income growth (YoY) | — | +11.7% | +11.6% | +21.5% | -7.1% | +34.8% | +21.9% | -7.5% | +2.9% | +45.8% | -0.8% | -34.1% | +45.9% | +27.5% | -35.4% | -16.2% | +422.3% |
| Profit margin | 19.2% | 18.9% | 18.3% | 19.1% | 15.8% | 19.5% | 20.7% | 18.5% | 16.9% | 21.9% | 19.8% | 13.0% | 15.6% | 18.6% | 7.8% | 4.1% | 18.3% |